Back
Open Access

Tools for risk assessment and decision support in atrial fibrillation: present and future.

logo

Session: Personalized treatment strategies for stroke prevention in atrial fibrillation - a perspective 5 years after ARISTOTLE
Topic: Atrial fibrillation (AF)
Speaker: Professor L. Wallentin (Uppsala, SE)
Sponsored by Bristol-Myers Squibb and Pfizer Alliance
Event: ESC Congress 2016

Congress Presentation

About the speaker

Professor Lars Wallentin

Uppsala University, Uppsala (Sweden)
18 presentations
1 follower

4 more presentations in this session

Introduction: Need for updated treatment strategies in atrial fibrillation.

Speaker: Professor P. Kirchhof (Hamburg, DE)

Access
Video
Thumbnail

Optimizing stroke prevention: Lessons from ARISTOTLE and other trials.

Speaker: Professor C. Granger (Durham, US)

Access
Video
Thumbnail

Strategies for oral anticoagulation with renal dysfunction.

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Access
Video
Thumbnail

Personalized treatment strategies for stroke prevention in atrial fibrillation: questions and answers.

Speaker: Professor J. Alexander (Durham, US)

Access
Video
Thumbnail

Access the full session

Personalized treatment strategies for stroke prevention in atrial fibrillation - a perspective 5 years after ARISTOTLE

Speakers: Professor L. Wallentin, Professor P. Kirchhof, Professor C. Granger, Professor S. Hohnloser, Professor J. Alexander
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb